Creighton Christopher J, Leo Gregory C, Du Yanming, Reitz Allen B
Drug Discovery Division, PO Box 776, Welsh and McKean Rds., Johnson & Johnson Pharmaceutical Research and Development, LLC, Spring House, PA 19477-0777, USA.
Bioorg Med Chem. 2004 Aug 15;12(16):4375-85. doi: 10.1016/j.bmc.2004.06.015.
As part of a program to identify novel scaffolds that adopt defined secondary structure when incorporated into peptides, we have designed and prepared a library of constrained eight-membered ring lactams based upon 7-amino-8-oxo-1,2,3,6,7-pentahydroazocine-2-carboxylic acid. Ring closing metathesis (RCM) was employed as the key step, proceeding in high yields to afford the Z olefin. In this reaction sequence, the first generation benzylidene ruthenium RCM catalyst was superior to the second-generation imidazoline catalyst, which gave extensive oligomerization at higher concentrations. Conformational analysis of the 2S,7S and 2R,7S stereoisomers revealed that the 2R,7S isomer is a Type VIa beta-turn in the solid state (X-ray crystal structure) and in water (NMR analysis). The Type VIa beta-turn is relatively rare, typically bearing the cis amide bond found in proline-containing sequences. The 2S,7S diastereomer has an extended geometry of the pendent amide chains. The corresponding saturated derivatives (7-amino-8-oxoazocane-2-carboxylic acid) were also synthesized and investigated. The 2S,7S azocane bears an extended geometry and mimics the C(+) conformer of ox-[Cys-Cys], found in a variety of naturally occurring peptides. The scaffolds described here are useful for the design of constrained peptidomimics with defined secondary structure.
作为鉴定新型支架的项目的一部分,当这些支架被纳入肽中时会呈现特定的二级结构。我们基于7-氨基-8-氧代-1,2,3,6,7-五氢氮杂辛烷-2-羧酸设计并制备了一系列受限的八元环内酰胺库。关环复分解反应(RCM)被用作关键步骤,反应以高产率进行,得到Z烯烃。在这个反应序列中,第一代亚苄基钌RCM催化剂优于第二代咪唑啉催化剂,第二代催化剂在较高浓度下会产生大量低聚反应。对2S,7S和2R,7S立体异构体的构象分析表明,2R,7S异构体在固态(X射线晶体结构)和水中(NMR分析)是VIa型β-转角。VIa型β-转角相对较少见,通常带有含脯氨酸序列中发现的顺式酰胺键。2S,7S非对映异构体具有悬垂酰胺链的伸展几何结构。还合成并研究了相应的饱和衍生物(7-氨基-8-氧代氮杂环辛烷-2-羧酸)。2S,7S氮杂环辛烷具有伸展的几何结构,模拟了在多种天然存在的肽中发现的ox-[Cys-Cys]的C(+)构象异构体。这里描述的支架可用于设计具有特定二级结构的受限肽模拟物。